Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
about
Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health.Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil.
P2860
Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toward a new 'EPOCH': optimisi ...... itors for erectile dysfunction
@en
Toward a new 'EPOCH': optimisi ...... tors for erectile dysfunction.
@nl
type
label
Toward a new 'EPOCH': optimisi ...... itors for erectile dysfunction
@en
Toward a new 'EPOCH': optimisi ...... tors for erectile dysfunction.
@nl
prefLabel
Toward a new 'EPOCH': optimisi ...... itors for erectile dysfunction
@en
Toward a new 'EPOCH': optimisi ...... tors for erectile dysfunction.
@nl
P2093
P2860
P921
P1476
Toward a new 'EPOCH': optimisi ...... itors for erectile dysfunction
@en
P2093
R Sadovsky
S Sorsaburu
S W Gutkin
P2860
P304
P356
10.1111/J.1742-1241.2009.02119.X
P5008
P577
2009-08-01T00:00:00Z